Immix Biopharma (IMMX) Share-based Compensation (2021 - 2026)
Immix Biopharma (IMMX) posted Share-based Compensation of $910,640 for Q2 2026, up 133.7% from $389,702 a year earlier and up 58.2% from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Share-based Compensation (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Immix Biopharma was $2.53 million, down 6.3% year-over-year; for FY2025, it was $2.44 million, down 19.2% from FY2024.
- Annual Share-based Compensation shows a four-year compound annual growth rate of 82.7% (FY2021 to FY2025).
- In prior years, Immix Biopharma's Share-based Compensation was $3.02 million in FY2024 (+17.7%), $2.57 million in FY2023 (+311.1%), $624,069 in FY2022 (+185.0%) and $218,983 in FY2021.
- The Q2 2026 figure stands as the highest quarterly Share-based Compensation since Q1 2024.
- On a year-over-year basis, Share-based Compensation increased in 1 of the last eight quarters, with an average decline of 4.4%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q1 2023, with growth of 407.0%; the weakest was Q2 2025, with a decline of 38.9%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $575,565 (Q1 2026), $570,796 (Q4 2025) and $470,471 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Immix Biopharma | 820.51 Mn | 820.51 Mn | - | 910,640.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 910,640.00 |
| Mar 31, 2026 | 575,565.00 |
| Dec 31, 2025 | 570,796.00 |
| Sep 30, 2025 | 470,471.00 |
| Jun 30, 2025 | 389,702.00 |
| Mar 31, 2025 | 868,359.00 |
| Dec 31, 2024 | 705,653.00 |
| Sep 30, 2024 | 733,806.00 |
| Jun 30, 2024 | 637,850.00 |
| Mar 31, 2024 | 943,264.00 |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 737,325.00 |
| Jun 30, 2023 | 447,656.00 |
| Mar 31, 2023 | 329,919.00 |
| Dec 31, 2022 | 230,094.00 |
| Sep 30, 2022 | 213,192.00 |
| Jun 30, 2022 | 115,709.00 |
| Mar 31, 2022 | 65,074.00 |
| Dec 31, 2021 | 122,152.00 |
| Sep 30, 2021 | 61,860.00 |
API Access
Immix Biopharma Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();